Quick Answer
LeonaBio, Inc. reported Total Assets of $92.15 million for fiscal year 2025.
LeonaBio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $92.15M | +56.8% |
| 2024 | $58.78M | -63.3% |
| 2023 | $160.25M | -37.9% |
| 2022 | $258.15M | -22.2% |
| 2021 | $332.01M | +18.8% |
| 2020 | $279.56M | +12671.3% |
| 2019 | $2.19M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.03M | -65.2% | -15.5% |
| June 30, 2025 | $35.55M | -68.1% | -18.3% |
| March 31, 2025 | $43.51M | -67.4% | -26.0% |
| December 31, 2024 | $58.78M | -63.3% | -31.8% |
| September 30, 2024 | $86.25M | -53.3% | -22.5% |
| June 30, 2024 | $111.25M | -46.5% | -16.6% |
| March 31, 2024 | $133.46M | -42.7% | -16.7% |
| December 31, 2023 | $160.25M | -37.9% | -13.2% |
- LeonaBio, Inc. showed an increase of +56.8% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, LeonaBio, Inc.’s total assets has grown by 4109.7% (from $2.19 million to $92.15 million).
- The most recent figure is from LeonaBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: